BUVAMED
ActiveSummary
BUVAMED has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €897,642 and a net result of €388,531. Equity is growing by ~29.2% per year across the filed fiscal years. Its solvency ranks better than 48% of 16810 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency87▼-13
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €80,000 at 30 days acceptable
Liquidity ample (current ratio 11.83 against 8.54 in 2024; short-term debt: 5% and cash: 26.5% of total assets), and 38.4% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
61.6%
Return on assets
26.6%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 7 filingsDeviation from the deadline
2025
31 d late
2024
29 d late
2023
on the day
2022
18 d late
2021
27 d early
2020
31 d early
2019
9 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 2 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 18 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€897,642▲ 40.8%
2024 · €637,372
Total assets
€1.5m▲ 82.2%
2024 · €800,243
Net result
€388,531▼ 5.1%
2024 · €409,250
Working capital
€788,119▲ 45.5%
2024 · €541,795
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€504,770▲ 47.5%€461,275▼ 8.6%€524,850▲ 13.8%€570,676▲ 8.7%€545,179▼ 4.5%
Net result€383,429above the sector's middle half▲ 47.1%€336,206above the sector's middle half▼ 12.3%€373,213above the sector's middle half▲ 11.0%€409,250above the sector's middle half▲ 9.7%€388,531above the sector's middle half▼ 5.1%
Equity€693,270above the sector's middle half▲ 124%€125,835within the sector's middle half▼ 81.8%€373,364above the sector's middle half▲ 197%€637,372above the sector's middle half▲ 70.7%€897,642above the sector's middle half▲ 40.8%
Total assets€777,457above the sector's middle half▲ 91.0%€291,858within the sector's middle half▼ 62.5%€516,655within the sector's middle half▲ 77.0%€800,243above the sector's middle half▲ 54.9%€1.5mabove the sector's middle half▲ 82.2%
Debt€84,187▼ 13.3%€166,023▲ 97.2%€143,291▼ 13.7%€162,871▲ 13.7%€560,463▲ 244%
Working capital€672,133above the sector's middle half▲ 123%€95,589within the sector's middle half▼ 85.8%€275,205above the sector's middle half▲ 188%€541,795above the sector's middle half▲ 96.9%€788,119above the sector's middle half▲ 45.5%
Solvency89.2%above the sector's middle half▲ 13.0pp43.1%within the sector's middle half▼ 46.1pp72.3%within the sector's middle half▲ 29.2pp79.6%within the sector's middle half▲ 7.4pp61.6%within the sector's middle half▼ 18.1pp
Current ratio16.55above the sector's middle half▲ 11.701.66within the sector's middle half▼ 14.894.39within the sector's middle half▲ 2.738.54above the sector's middle half▲ 4.1511.83above the sector's middle half▲ 3.29
Return on assets (ROA)49.3%above the sector's middle half▼ 14.7pp115.2%above the sector's middle half▲ 65.9pp72.2%above the sector's middle half▼ 43.0pp51.1%above the sector's middle half▼ 21.1pp26.6%within the sector's middle half▼ 24.5pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 4% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.5m
Fixed assets
€597,239 ▲ 220%
Current assets
€860,866 ▲ 40.3%
Equity and liabilities €1.5m
Equity
€897,642 ▲ 40.8%
Debt
€560,463 ▲ 244%
Debt's share of the balance-sheet total rises from 20.4% to 38.4%. Equity and debt are higher.
Key figures and ratios
EBITDA
€585,427▼
2024 · €598,861
Cash flow
€428,779▼
2024 · €437,436
Debt to equity
0.62▲
2024 · 0.26
ROE
43.3%▼
2024 · 64.2%
Interest coverage
165.86▼
2024 · 204.36
Debt ≤ 1 year
€72,747▲
2024 · €71,866
Debt > 1 year
€487,716▲
2024 · €91,005
Income taxes
€162,669▼
2024 · €167,578
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 6,781 companies that looked in July 2024 the way this one looks now, 0.6% went bankrupt within 24 months and 97% are still going.
- Small
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.6%
went bankrupt
2.7%
stopped otherwise
97%
still going
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,781 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | €15,468 | €0 | €5,000 | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €20,577 | €22,754 | €29,349 | €28,186 | €40,248 | ▲ 42.8% |
| Other operating charges640/8 | €3,818 | €4,021 | €3,433 | €2,871 | €45,652 | ▲ 1,490% |
| Non-recurring operating charges66A | - | - | - | €10,541 | €0 | ▼ 100% |
| Gross operating margin9900 | €529,166 | €488,050 | €557,631 | €612,273 | €631,079 | ▲ 3.1% |
| Operating profit (loss)9901 | €504,770 | €461,275 | €524,850 | €570,676 | €545,179 | ▼ 4.5% |
| Financial income75/76B | €3,900 | €1,800 | €1,800 | €9,082 | €9,550 | ▲ 5.1% |
| Recurring financial income75 | €3,900 | €1,800 | €1,800 | €9,082 | €9,550 | ▲ 5.1% |
| Financial charges65/66B | €793 | €469 | €3,178 | €2,930 | €3,530 | ▲ 20.4% |
| Recurring financial charges65 | €793 | €469 | €3,178 | €2,930 | €3,530 | ▲ 20.4% |
| Profit (loss) for the period before taxes9903 | €507,877 | €462,606 | €523,471 | €576,827 | €551,200 | ▼ 4.4% |
| Income taxes67/77 | €124,449 | €126,400 | €150,258 | €167,578 | €162,669 | ▼ 2.9% |
| Profit (loss) for the period9904 | €383,429 | €336,206 | €373,213 | €409,250 | €388,531 | ▼ 5.1% |
| Profit (loss) for the period to be appropriated9905 | €383,429 | €336,206 | €373,213 | €409,250 | €388,531 | ▼ 5.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €777,457 | €291,858 | €516,655 | €800,243 | €1.5m | ▲ 82.2% |
| Fixed assets21/28 | €62,089 | €51,010 | €160,306 | €186,582 | €597,239 | ▲ 220% |
| Tangible fixed assets22/27 | €62,089 | €51,010 | €160,306 | €186,582 | €597,239 | ▲ 220% |
| Land and buildings22 | - | - | €46,017 | €43,640 | €487,410 | ▲ 1,017% |
| Plant, machinery and equipment23 | - | - | - | €2,064 | €1,581 | ▼ 23.4% |
| Furniture and vehicles24 | €19,264 | €18,891 | €87,576 | €136,145 | €103,160 | ▼ 24.2% |
| Leasing and similar rights25 | €42,825 | €32,119 | €21,413 | €0 | - | - |
| Other tangible fixed assets26 | - | - | €5,300 | €4,734 | €5,088 | ▲ 7.5% |
| Current assets29/58 | €715,368 | €240,848 | €356,349 | €613,661 | €860,866 | ▲ 40.3% |
| Amounts receivable after more than one year29 | €195,000 | €60,000 | €60,000 | €60,000 | €60,000 | = |
| Trade receivables290 | €195,000 | - | - | - | - | - |
| Other amounts receivable291 | - | €60,000 | €60,000 | €60,000 | €60,000 | = |
| Amounts receivable within one year40/41 | €24,219 | €14,100 | €14,100 | €49,180 | €56,532 | ▲ 15.0% |
| Trade receivables40 | €12,551 | €0 | - | €12,657 | €20,010 | ▲ 58.1% |
| Other amounts receivable41 | €11,669 | €14,100 | €14,100 | €36,522 | €36,522 | = |
| Current investments50/53 | €18,900 | €18,900 | €0 | €250,000 | €351,000 | ▲ 40.4% |
| Cash at bank and in hand54/58 | €472,109 | €145,194 | €275,223 | €247,987 | €386,033 | ▲ 55.7% |
| Deferred charges and accrued income490/1 | €5,139 | €2,654 | €7,026 | €6,494 | €7,300 | ▲ 12.4% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €777,457 | €291,858 | €516,655 | €800,243 | €1.5m | ▲ 82.2% |
| Equity10/15 | €693,270 | €125,835 | €373,364 | €637,372 | €897,642 | ▲ 40.8% |
| Contributions10/11 | €18,600 | €200 | €200 | €200 | €200 | = |
| Reserves13 | - | €125,635 | €373,164 | €637,172 | €897,442 | ▲ 40.8% |
| Distributable reserves133 | - | €125,635 | €373,164 | €637,172 | €897,442 | ▲ 40.8% |
| Profit (loss) carried forward14 | €674,670 | €0 | €0 | €0 | €0 | - |
| Amounts payable17/49 | €84,187 | €166,023 | €143,291 | €162,871 | €560,463 | ▲ 244% |
| Amounts payable after more than one year17 | €40,952 | €20,764 | €62,147 | €91,005 | €487,716 | ▲ 436% |
| Financial debts170/4 | €40,952 | €20,764 | €62,147 | €91,005 | €487,716 | ▲ 436% |
| Amounts payable within one year42/48 | €43,235 | €145,259 | €81,144 | €71,866 | €72,747 | ▲ 1.2% |
| Current portion of amounts payable after more than one year42 | €20,022 | €20,188 | €24,820 | €31,473 | €48,289 | ▲ 53.4% |
| Trade debts44 | €396 | €637 | €20 | €1,256 | €3,255 | ▲ 159% |
| Suppliers440/4 | €396 | €637 | €20 | €1,256 | €3,255 | ▲ 159% |
| Taxes, remuneration and social security45 | €20,850 | €90,926 | €49,543 | €33,841 | €21,203 | ▼ 37.3% |
| Taxes450/3 | €5,850 | €75,926 | €49,543 | €33,841 | €21,203 | ▼ 37.3% |
| Remuneration and social security454/9 | €15,000 | €15,000 | €0 | - | - | - |
| Other amounts payable47/48 | €1,967 | €33,507 | €6,761 | €5,296 | €0 | ▼ 100% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €383,429 | €336,206 | €373,213 | €409,250 | €388,531 | ▼ 5.1% |
| + Depreciation and write-downs630 | €20,577 | €22,754 | €29,349 | €28,186 | €40,248 | ▲ 42.8% |
| Operating cash flow (approximation) | €404,006 | €358,960 | €402,562 | €437,436 | €428,779 | ▼ 2.0% |
| Investment in fixed assets (approximation) | - | -€11,675 | -€138,646 | -€54,462 | -€450,905 | ▼ 728% |
| Change in cash | - | -€326,916 | €130,029 | -€27,235 | €138,046 | ▲ 607% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
31-12
Financial
Highest result since 2019net €409,250 ▲9.7%
Operating result €570,676, net result €409,250, both a record.
31-12
Financial
Equity above €500,000Eq €637,372 ▲70.7%
6 profitable years in a row build equity to €637,372.
31-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Liquidity triplescurrent ratio 4.39
Current ratio from 1.66 to 4.39; short-term debt falls from €145,259 to €81,144.
31-12
Financial
Equity above €200,000Eq €373,364 ▲197%
5 profitable years in a row build equity to €373,364.
18-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 18 days late
2022
04-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Liquidity triplescurrent ratio 16.55
Current ratio from 4.85 to 16.55; short-term debt falls from €78,262 to €43,235.
31-12
Financial
Equity above €500,000Eq €693,270 ▲124%
3 profitable years in a row build equity to €693,270.
30-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Equity above €200,000Eq €309,841 ▲75.3%
2 profitable years in a row build equity to €309,841.
22-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
No directors read yet: 0 of 4 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Genk · 1 establishment unit since 2018
Ground area
1,529 m²
Building footprint
195 m²
Volume, LiDAR
598 m³
Parcel 71306G0157/00T010, Flanders · tallest building 8.3 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Dr. Ben Van Bylen
since 20182.283.303.388
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71306G0157/00T010 | Flanders | 1,529 m² | 1 · 195 m² | 8.3 m · 1 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
875500K6LSLKADLKB848
Similar companies · same sector, comparable size
CENTRE MONTOIS DE RECHERCHESUR LES ARTHRITES
BE 0860.793.044
Jurbise · Eq €897,186
ESTHETICARE
BE 0650.972.839
Zoersel · Eq €898,594
DR. STEFANIE CROMHEECKE
BE 0891.444.648
Schoten · Eq €896,466
Dr. Van Renterghem Debbie
BE 0534.755.852
Schilde · Eq €896,365
Dr. W. Heggermont, cardiologie
BE 0689.768.483
Aalst · Eq €899,013
Of 16,625 companies in this sector we hold annual accounts for 7,989. 5,898 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company details
Identification
Legal formPrivate limited company
Founded28-12-2018
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0716921654
Also
9925:BE0716921654
Registered
14-11-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.